https://de.marketscreener.com/kurs/aktie/NUVATION-BIO-INC-111170007/news/Nuvation-Bio-Inc-verabreicht-ersten-Patienten-in-Phase-1-2-Studie-von-NUV-1511-zur-Behandlung-von-f-46203071/?utm_source=telegram&utm_medium=social&utm_campaign=share